Minerva Advisors LLC Has $2.82 Million Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Minerva Advisors LLC increased its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 461.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,328 shares of the medical instruments supplier's stock after acquiring an additional 34,794 shares during the quarter. Utah Medical Products comprises about 1.6% of Minerva Advisors LLC's investment portfolio, making the stock its 19th largest position. Minerva Advisors LLC owned approximately 1.22% of Utah Medical Products worth $2,818,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in UTMD. Copeland Capital Management LLC bought a new stake in Utah Medical Products in the third quarter valued at about $53,000. Allspring Global Investments Holdings LLC bought a new stake in Utah Medical Products in the second quarter valued at about $83,000. Victory Capital Management Inc. increased its holdings in Utah Medical Products by 124.4% in the second quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier's stock valued at $179,000 after purchasing an additional 1,482 shares during the last quarter. EntryPoint Capital LLC increased its holdings in Utah Medical Products by 124.1% in the first quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier's stock valued at $230,000 after purchasing an additional 1,794 shares during the last quarter. Finally, GSA Capital Partners LLP bought a new stake in Utah Medical Products in the third quarter valued at about $231,000. Institutional investors and hedge funds own 69.60% of the company's stock.

Utah Medical Products Stock Performance

Shares of NASDAQ UTMD traded down $1.40 during trading hours on Tuesday, reaching $64.69. 25,476 shares of the stock were exchanged, compared to its average volume of 22,208. The stock's fifty day simple moving average is $66.03 and its 200 day simple moving average is $67.33. Utah Medical Products, Inc. has a 52 week low of $63.38 and a 52 week high of $87.21. The firm has a market capitalization of $219.30 million, a price-to-earnings ratio of 15.48 and a beta of 0.08.

Utah Medical Products Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Monday, December 16th will be paid a $0.305 dividend. This is a positive change from Utah Medical Products's previous quarterly dividend of $0.30. The ex-dividend date is Monday, December 16th. This represents a $1.22 annualized dividend and a dividend yield of 1.89%. Utah Medical Products's dividend payout ratio (DPR) is presently 28.10%.

Analyst Ratings Changes

Separately, StockNews.com downgraded Utah Medical Products from a "strong-buy" rating to a "buy" rating in a report on Thursday, November 7th.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.